Entrada Therapeutics Inc Free Cash Flow Generation Index

Latest as of June 2024: 0.97x

Entrada Therapeutics Inc free cash flow generation index. Entrada Therapeutics Inc (TRDA) has a Free Cash Flow Generation Index of 0.97x as of June 2024. Free cash flow of $38.79 Million represents 1% of operating cash flow ($39.83 Million).

FCF Generation Index

0.97x
Free Cash Flow / Operating CF

Free Cash Flow

$38.79 Million
USD

Operating Cash Flow

$39.83 Million
USD

Capital Expenditures

$1.05 Million
USD

Free Cash Flow Generation Index of Entrada Therapeutics Inc (2023–2023)

Free cash flow generation index of Entrada Therapeutics Inc from 2023 to 2023. Historical FCF Generation Index trend for Entrada Therapeutics Inc across 1 annual periods. See TRDA financial flexibility score to measure the company's free cash flow as a share of total liabilities.

Entrada Therapeutics Inc Free Cash Flow Generation Index by Year (2023–2023)

Entrada Therapeutics Inc free cash flow generation index by year from 2023 to 2023. Year-by-year Free Cash Flow Generation Index for Entrada Therapeutics Inc. For the full cash flow conversion analysis, see TRDA cash generation efficiency.

Year FCG Index Free Cash Flow (USD) Operating CF Capital Expenditures YoY Change
2023 0.96x $134.19 Million $139.80 Million $5.61 Million —
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).